The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer

Songbai Lin, Dongsheng Wang, Smita Iyer, Amr M. Ghaleb, Hyunsuk Shim, Vincent W. Yang, Jerold Chun, C. Chris Yun

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background & Aims: Chronic inflammation is a risk factor for colon cancer (CC). Lysophosphatidic acid (LPA), a naturally produced phospholipid, mediates multiple effects that are vital to disease process, including inflammation and cancer. The expression of LPA receptor 2 (LPA2) is up-regulated in several types of cancer, including ovarian and colon cancer, but the importance of LPA and LPA2 in the development and progression of CC is unclear. In this study, we sought to determine whether LPA and LPA2 regulate the progression of CC in vivo. Methods: We examined the potential role of LPA in CC progression by administering LPA to mice heterozygous for the adenomatous polyposis coli (Apc) allele. We determined the loss of LPA2 function in tumorigenesis in the colon by treating mice with genetic deletion of LPA2 (LPA2 -/-) with azoxymethane and dextran sulfate sodium. Results: We found that LPA increased tumor incidence in Apcmin/+ mice. LPA2 -/- mice showed reduced mucosal damage and fewer tumors than wild-type (WT) mice. Reduced epithelial cell proliferation and decreases in β-catenin, Krüppel-like factor 5, and cyclooxygenase-2 expression were observed in LPA2 -/- mice. Unlike WT mice, induction of monocyte chemoattractant protein-1 and macrophage migration inhibitory factor was significantly attenuated in LPA2 -/- mice with reduced infiltration by macrophages. Conclusions: These results show that LPA is capable of promoting tumorigenesis in the colon. The absence of LPA2 attenuates several effects that contribute to cancer progression in vivo, and, hence, the current study identifies LPA2 as an important modulator of CC.

Original languageEnglish (US)
Pages (from-to)1711-1720
Number of pages10
JournalGastroenterology
Volume136
Issue number5
DOIs
StatePublished - May 1 2009
Externally publishedYes

Fingerprint

Lysophosphatidic Acid Receptors
Colitis
Theoretical Models
Colonic Neoplasms
Neoplasms
Colon
Carcinogenesis
Azoxymethane
Macrophage Migration-Inhibitory Factors
Inflammation
Catenins
Dextran Sulfate
Adenomatous Polyposis Coli
Cyclooxygenase 2
Ovarian Neoplasms

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lin, S., Wang, D., Iyer, S., Ghaleb, A. M., Shim, H., Yang, V. W., ... Yun, C. C. (2009). The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer. Gastroenterology, 136(5), 1711-1720. https://doi.org/10.1053/j.gastro.2009.01.002

The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer. / Lin, Songbai; Wang, Dongsheng; Iyer, Smita; Ghaleb, Amr M.; Shim, Hyunsuk; Yang, Vincent W.; Chun, Jerold; Yun, C. Chris.

In: Gastroenterology, Vol. 136, No. 5, 01.05.2009, p. 1711-1720.

Research output: Contribution to journalArticle

Lin, S, Wang, D, Iyer, S, Ghaleb, AM, Shim, H, Yang, VW, Chun, J & Yun, CC 2009, 'The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer', Gastroenterology, vol. 136, no. 5, pp. 1711-1720. https://doi.org/10.1053/j.gastro.2009.01.002
Lin, Songbai ; Wang, Dongsheng ; Iyer, Smita ; Ghaleb, Amr M. ; Shim, Hyunsuk ; Yang, Vincent W. ; Chun, Jerold ; Yun, C. Chris. / The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer. In: Gastroenterology. 2009 ; Vol. 136, No. 5. pp. 1711-1720.
@article{9b30ae3fc43b420096f49afe6a833eb6,
title = "The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer",
abstract = "Background & Aims: Chronic inflammation is a risk factor for colon cancer (CC). Lysophosphatidic acid (LPA), a naturally produced phospholipid, mediates multiple effects that are vital to disease process, including inflammation and cancer. The expression of LPA receptor 2 (LPA2) is up-regulated in several types of cancer, including ovarian and colon cancer, but the importance of LPA and LPA2 in the development and progression of CC is unclear. In this study, we sought to determine whether LPA and LPA2 regulate the progression of CC in vivo. Methods: We examined the potential role of LPA in CC progression by administering LPA to mice heterozygous for the adenomatous polyposis coli (Apc) allele. We determined the loss of LPA2 function in tumorigenesis in the colon by treating mice with genetic deletion of LPA2 (LPA2 -/-) with azoxymethane and dextran sulfate sodium. Results: We found that LPA increased tumor incidence in Apcmin/+ mice. LPA2 -/- mice showed reduced mucosal damage and fewer tumors than wild-type (WT) mice. Reduced epithelial cell proliferation and decreases in β-catenin, Kr{\"u}ppel-like factor 5, and cyclooxygenase-2 expression were observed in LPA2 -/- mice. Unlike WT mice, induction of monocyte chemoattractant protein-1 and macrophage migration inhibitory factor was significantly attenuated in LPA2 -/- mice with reduced infiltration by macrophages. Conclusions: These results show that LPA is capable of promoting tumorigenesis in the colon. The absence of LPA2 attenuates several effects that contribute to cancer progression in vivo, and, hence, the current study identifies LPA2 as an important modulator of CC.",
author = "Songbai Lin and Dongsheng Wang and Smita Iyer and Ghaleb, {Amr M.} and Hyunsuk Shim and Yang, {Vincent W.} and Jerold Chun and Yun, {C. Chris}",
year = "2009",
month = "5",
day = "1",
doi = "10.1053/j.gastro.2009.01.002",
language = "English (US)",
volume = "136",
pages = "1711--1720",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated Cancer

AU - Lin, Songbai

AU - Wang, Dongsheng

AU - Iyer, Smita

AU - Ghaleb, Amr M.

AU - Shim, Hyunsuk

AU - Yang, Vincent W.

AU - Chun, Jerold

AU - Yun, C. Chris

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Background & Aims: Chronic inflammation is a risk factor for colon cancer (CC). Lysophosphatidic acid (LPA), a naturally produced phospholipid, mediates multiple effects that are vital to disease process, including inflammation and cancer. The expression of LPA receptor 2 (LPA2) is up-regulated in several types of cancer, including ovarian and colon cancer, but the importance of LPA and LPA2 in the development and progression of CC is unclear. In this study, we sought to determine whether LPA and LPA2 regulate the progression of CC in vivo. Methods: We examined the potential role of LPA in CC progression by administering LPA to mice heterozygous for the adenomatous polyposis coli (Apc) allele. We determined the loss of LPA2 function in tumorigenesis in the colon by treating mice with genetic deletion of LPA2 (LPA2 -/-) with azoxymethane and dextran sulfate sodium. Results: We found that LPA increased tumor incidence in Apcmin/+ mice. LPA2 -/- mice showed reduced mucosal damage and fewer tumors than wild-type (WT) mice. Reduced epithelial cell proliferation and decreases in β-catenin, Krüppel-like factor 5, and cyclooxygenase-2 expression were observed in LPA2 -/- mice. Unlike WT mice, induction of monocyte chemoattractant protein-1 and macrophage migration inhibitory factor was significantly attenuated in LPA2 -/- mice with reduced infiltration by macrophages. Conclusions: These results show that LPA is capable of promoting tumorigenesis in the colon. The absence of LPA2 attenuates several effects that contribute to cancer progression in vivo, and, hence, the current study identifies LPA2 as an important modulator of CC.

AB - Background & Aims: Chronic inflammation is a risk factor for colon cancer (CC). Lysophosphatidic acid (LPA), a naturally produced phospholipid, mediates multiple effects that are vital to disease process, including inflammation and cancer. The expression of LPA receptor 2 (LPA2) is up-regulated in several types of cancer, including ovarian and colon cancer, but the importance of LPA and LPA2 in the development and progression of CC is unclear. In this study, we sought to determine whether LPA and LPA2 regulate the progression of CC in vivo. Methods: We examined the potential role of LPA in CC progression by administering LPA to mice heterozygous for the adenomatous polyposis coli (Apc) allele. We determined the loss of LPA2 function in tumorigenesis in the colon by treating mice with genetic deletion of LPA2 (LPA2 -/-) with azoxymethane and dextran sulfate sodium. Results: We found that LPA increased tumor incidence in Apcmin/+ mice. LPA2 -/- mice showed reduced mucosal damage and fewer tumors than wild-type (WT) mice. Reduced epithelial cell proliferation and decreases in β-catenin, Krüppel-like factor 5, and cyclooxygenase-2 expression were observed in LPA2 -/- mice. Unlike WT mice, induction of monocyte chemoattractant protein-1 and macrophage migration inhibitory factor was significantly attenuated in LPA2 -/- mice with reduced infiltration by macrophages. Conclusions: These results show that LPA is capable of promoting tumorigenesis in the colon. The absence of LPA2 attenuates several effects that contribute to cancer progression in vivo, and, hence, the current study identifies LPA2 as an important modulator of CC.

UR - http://www.scopus.com/inward/record.url?scp=65249173527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65249173527&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2009.01.002

DO - 10.1053/j.gastro.2009.01.002

M3 - Article

C2 - 19328876

AN - SCOPUS:65249173527

VL - 136

SP - 1711

EP - 1720

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5

ER -